Evaluating HPV-negative CIN2+ in the ATHENA trial

Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study

(2015) Katsiaryna Holl et al.   INTERNATIONAL JOURNAL OF CANCER

Are 20 human papillomavirus types causing cervical cancer?

(2014) Marc Arbyn et al.   JOURNAL OF PATHOLOGY

Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer

(2014) Gordana Halec et al.   JOURNAL OF PATHOLOGY

Squamous anal cancer: Patient characteristics and HPV type distribution

(2013) N. Ouhoummane et al.   Cancer Epidemiology

The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated Lesions

(2012) Teresa M. Darragh et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology

(2011) Mark H. Stoler et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

The ATHENA human papillomavirus study: design, methods, and baseline results

(2011) Thomas C. Wright et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

One virus, one lesion-individual components of CIN lesions contain a specific HPV type

(2011) Wim Quint et al.   JOURNAL OF PATHOLOGY